Ascend Advanced Therapies
Pre-clinicalAscend is a gene to GMP development partner working to support the next-generation of life-science innovators in bringing advanced therapy products to patients. Our team of experts offer unparalleled insight and collaboration in delivering your products from the bench through the clinic and beyond.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $29.8M
About
Ascend is a gene to GMP development partner working to support the next-generation of life-science innovators in bringing advanced therapy products to patients. Our team of experts offer unparalleled insight and collaboration in delivering your products from the bench through the clinic and beyond.
Cell TherapyGene Therapy
Funding History
3Total raised:$29.8M
Seed$10MJun 15, 2022
Series A$15MJan 15, 2022
Seed$4.8MApr 15, 2020